Month: January 2024

Very strong support from Casino Group’s shareholders and creditors meeting as classes of parties affected by the draft accelerated safeguard plans ***Addendum*** Paris, 12 January 2024 Following on from its press release on the results of the class vote, Groupe Casino points out that the rejection of the accelerated safeguard plan by one of the classes will have no impact on its implementation under the inter-class forced application mechanism. *** This press release was prepared solely for information purposes and should not be construed as a solicitation or an offer to buy or sell securities or related financial instruments. Likewise, it does not provide and should not be treated as providing investment advice. It has no connection with the specific investment objectives, financial situation or needs of any receiver. No representation...

CARSON CITY, NV, Jan. 12, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – LeapCharger Corporation (OTC: LCCN) (“LeapCharger” or the “Company”), an electric vehicle (EV) charging company with disruptive and innovative technology providing eco-friendly and sustainable solutions, today announced that Praveenkumar Vijayakumar, our CEO and largest shareholder (the “Shareholder”), has agreed to return to authorized but unissued status a total of 32,000,000 shares of Company common stock. Once completed, the cancellation of the 32,000,000 shares of common stock will result in the decrease of issued and outstanding shares of the Company’s common stock from 53,275,906 to 21,275,906, or a 60% reduction in the Company’s issued and outstanding shares of common stock. In exchange for the return of the 32,000,000 shares of the Company’s...

Dr. Levy to Provide Perspective on Iopofosine I 131’s Potential in the Community Clinic Treatment Landscape of Waldenstrom’s Macroglobulinemia FLORHAM PARK, N.J., Jan. 12, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host a conference call with M. Yair Levy, M.D., director of hematologic malignancies research at Texas Oncology and investigator in the CLOVER WaM pivotal study of iopofosine I 131, on Friday, January 19, 2024 at 8:30 a.m. ET. Dr. Levy will join the Cellectar management team to discuss his perspective, as a community-based hemotologist, on the positive topline results of iopofosine I 131 in patients with relapsed/refractory...

Jyske Bank upgrades expectations of its earnings per share in 2023 to c. DKK 89, corresponding to a net profit for the year of c. DKK 5.9bn. Previously, Jyske Bank expected earnings per share of DKK 82-87 and net profit of DKK 5.4bn-5.7bn. The upgraded outlook reflects a net profit of c. DKK 1.8bn in the fourth quarter of 2023 driven by a favourable development in the financial markets, especially due to lower interest rates towards the end of the year. Loan impairment charges was an expense of c. DKK 30m in the quarter. Jyske Bank’s annual report for 2023 is expected to be published on 27 February 2024. Yours faithfully,    Jyske Bank   Contact: Birger Krøgh Nielsen, CFO, tel. +45 89 89 64 44AttachmentCorporate Announcement_20240112

Nanterre, 12 January 2024 VINCI to build electrical infrastructure in Senegal1,350 km of transmission lines and 8 very-high-voltage transformer stations Three years of works A €200 million contractVINCI Energies and Senelec have signed a €200 million contract to build an array of electricity transmission and distribution infrastructure. French authorities will contribute to the project’s financing. The works will last three years and employ a total of more than 1,000 people. They involve building 1,350 km of high-voltage and very-high-voltage overhead and underground transmission lines to connect several thousand homes. They also involve building eight very-high-voltage transformer stations. The grid management system will moreover be enhanced, for example with the addition of an interface to remotely manage operations and...

Terranet AB (“Terranet” or the “Company”) announces that the board of directors has today resolved to carry out a directed issue of units of approximately SEK 10 million, consisting of shares of series B and warrants of series TO8 to a number of pre-approached investors, including existing shareholders. In order to partly compensate the shareholders for the dilution resulting from the issue, the board of directors has also resolved on a directed issue of warrants of series TO8 to the Company, which will be transferred without consideration to all shareholders in the Company.        Directed issues of units The board of directors of Terranet has today resolved on a directed issue of a total of 71,428,569 units at a subscription price of SEK 0.14 per unit corresponding to SEK 0.07 per share. The issue proceeds amount...

Introduction of statutory transparency thresholds by Syensqo Brussels, Belgium – January 12, 2023 – 08:30 CET Pursuant to Article 18 of the Law of May 2, 2007  on disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market (the “Law”), SYENSQO SA (the “Company”) publishes the statutory transparency declaration thresholds. In accordance with Article 11 of the Articles of Association of the Company, the statutory thresholds for notification of participation have been set at 3% and 7.5% of the total existing voting rights, in addition to the legal thresholds of 5% and multiples of 5% of the total existing voting rights. Any individual or legal person who, individually or as a result of a concert within the meaning of the Law, directly or indirectly holds securities in the Company whose total number...